Early research (Phase 1)Study completedNCT03164109
What this trial is testing
A Phase 1, Randomized, Placebo-and Positive-Controlled Crossover Study to Determine the Effect of Single-Dose GC4419 on QTc Interval in Healthy Volunteers
Who this might be right for
Healthy VolunteersHealthy
Galera Therapeutics, Inc. 28